1. A phase 2b, randomized, double‐blind, multicenter, vehicle‐controlled study to assess the efficacy and safety of two crisaborole regimens in Japanese patients aged 2 years and older with mild‐to‐moderate atopic dermatitis. Issue 11 (26th August 2021) Authors: Fujita, Kayo; Yagi, Michio; Moriwaki, Shinichi; Yoshida, Mizuki; Graham, Daniela Journal: Journal of dermatology Issue: Volume 48:Issue 11(2021) Page Start: 1640 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0440 CHANGES IN KEY LABORATORY VALUES WITH TOFACITINIB 5 MG BID TREATMENT IN PATIENTS WITH PSORIATIC ARTHRITIS AND RHEUMATOID ARTHRITIS. (June 2019) Authors: Rigby, William; Burmester, Gerd Rüdiger; Fitzgerald, Oliver; Azevedo, Valderilio F.; Nash, Peter; Graham, Daniela; Wang, Cunshan; Jones, Thomas Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 1682 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Evaluation of the Effect of Abrocitinib on Drug Transporters by Integrated Use of Probe Drugs and Endogenous Biomarkers. Issue 3 (9th May 2022) Authors: Vourvahis, Manoli; Byon, Wonkyung; Chang, Cheng; Le, Vu; Diehl, Annette; Graham, Daniela; Tripathy, Sakambari; Raha, Nancy; Luo, Lina; Mathialagan, Sumathy; Dowty, Martin; Rodrigues, A. David; Malhotra, Bimal Journal: Clinical pharmacology & therapeutics Issue: Volume 112:Issue 3(2022) Page Start: 665 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. FRI0452 TOFACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS: ANALYSIS OF DERMATOLOGIC ENDPOINTS FROM 2 PHASE 3 STUDIES. (June 2019) Authors: Merola, Joseph F.; Papp, Kim; Nash, Peter; Gratacos-Masmitja, Jordi; Boehncke, Wolf-Henning; Thaçi, Diamant; Graham, Daniela; Hsu, Ming-Ann; Wang, Cunshan; Wu, Joseph; Young, Pamela Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 918 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Impact of baseline body mass index on the efficacy and safety of tofacitinib in patients with psoriatic arthritis. Issue 1 (15th January 2021) Authors: Giles, Jon T; Ogdie, Alexis; Gomez Reino, Juan J; Helliwell, Philip; Germino, Rebecca; Stockert, Lori; Young, Pamela; Joseph, Wael; Mundayat, Rajiv; Graham, Daniela; Ritchlin, Christopher Journal: RMD open Issue: Volume 7:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Impact of baseline body mass index on the efficacy and safety of tofacitinib in patients with psoriatic arthritis. Issue 1 (15th January 2021) Authors: Giles, Jon T; Ogdie, Alexis; Gomez Reino, Juan J; Helliwell, Philip; Germino, Rebecca; Stockert, Lori; Young, Pamela; Joseph, Wael; Mundayat, Rajiv; Graham, Daniela; Ritchlin, Christopher Journal: RMD open Issue: Volume 7:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Impact of baseline body mass index on the efficacy and safety of tofacitinib in patients with psoriatic arthritis. Issue 1 (15th January 2021) Authors: Giles, Jon T; Ogdie, Alexis; Gomez Reino, Juan J; Helliwell, Philip; Germino, Rebecca; Stockert, Lori; Young, Pamela; Joseph, Wael; Mundayat, Rajiv; Graham, Daniela; Ritchlin, Christopher Journal: RMD open Issue: Volume 7:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Impact of baseline body mass index on the efficacy and safety of tofacitinib in patients with psoriatic arthritis. Issue 1 (15th January 2021) Authors: Giles, Jon T; Ogdie, Alexis; Gomez Reino, Juan J; Helliwell, Philip; Germino, Rebecca; Stockert, Lori; Young, Pamela; Joseph, Wael; Mundayat, Rajiv; Graham, Daniela; Ritchlin, Christopher Journal: RMD open Issue: Volume 7:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data. Issue 11 (5th August 2020) Authors: Mease, Philip; Charles-Schoeman, Christina; Cohen, Stanley; Fallon, Lara; Woolcott, John; Yun, Huifeng; Kremer, Joel; Greenberg, Jeffrey; Malley, Wendi; Onofrei, Alina; Kanik, Keith S; Graham, Daniela; Wang, Cunshan; Connell, Carol; Valdez, Hernan; Hauben, Manfred; Hung, Eric; Madsen, Ann; Jones,... Journal: Annals of the rheumatic diseases Issue: Volume 79:Issue 11(2020) Page Start: 1400 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Outcomes of Pregnancies With Maternal/Paternal Exposure in the Tofacitinib Safety Databases for Ulcerative Colitis. Issue 12 (29th November 2018) Authors: Mahadevan, Uma; Dubinsky, Marla C; Su, Chinyu; Lawendy, Nervin; Jones, Thomas V; Marren, Amy; Zhang, Haiying; Graham, Daniela; Clowse, Megan E B; Feldman, Steven R; Baumgart, Daniel C Journal: Inflammatory bowel diseases Issue: Volume 24:Issue 12(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗